Product Description: DNA-PK-IN-8 is a highly potent, selective and orally active DNA-dependent protein kinase (DNA-PK) inhibitor with an IC50 value of 0.8 nM. DNA-PK-IN-8 exhibits synergistic antiproliferative activity against a series of cancer cell lines and significantly suppresses HL-60 tumor growth, when using in combination with Doxorubicin[1].
Applications: Cancer-Kinase/protease
Formula: C19H22N8O2
References: [1]Ding Z, et al. Discovery of novel 7,8-dihydropteridine-6(5H)-one-based DNA-PK inhibitors as potential anticancer agents via scaffold hopping strategy. Eur J Med Chem. 2022;237:114401.
CAS Number: 2823369-81-7
Molecular Weight: 394.43
Compound Purity: 99.74
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: DNA-PK